유리체망막 수술 기기 시장 : 제품 유형별, 수술 유형별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Vitreoretinal Surgery Devices Market By Product , By Surgery Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,279,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,518,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

유리체망막 수술 기기

유리체망막 수술 기기 시장은 2023년 23억 달러로 평가되며, 2024-2033년 연평균 5.9% 성장하여 2033년에는 41억 달러에 달할 것으로 예상됩니다.

유리체망막 수술 기기는 눈의 망막과 유리체에 초점을 맞춘 안과 수술에 필수적인 전문 장비입니다. 황반원공, 망막박리, 당뇨망막병증, 망막상막 등 다양한 망막 질환은 안구의 정상적인 해부학적 구조와 기능을 복원하고 회복하기 위해 이 장비를 사용하여 치료합니다. 장비의 혁신으로 최소침습적 수술이 가능해져 회복 시간이 단축되고 환자의 예후가 개선되고 있습니다.

특히 고령층에서 안과 수술의 보급률이 높아지면서 유리체망막 수술 기기 시장의 주요 촉진요인으로 작용하고 있습니다. 또한, 의료 시설에 대한 정부의 지출 증가는 유리체망막 수술 기기의 발전으로 이어져 의료 현장에서의 채택을 촉진하고 있습니다. 현재 수술 장비에 로봇 기술을 통합하는 것이 시장의 새로운 트렌드가 되고 있습니다. 이 기술은 복잡한 수술에서 인간의 기술을 능가하여 실수 가능성을 줄이고 정확도를 높이고 있습니다. 연구진은 로봇공학과 AI의 융합을 통해 스마트한 수술을 실현하는 것을 목표로 하고 있습니다.

그러나 유리체망막 수술 기기의 높은 초기 비용과 유지보수의 필요성으로 인해 소규모 의료시설은 투자를 망설이고 있습니다. 이는 다양한 신흥국 및 의료 서비스가 부족한 지역의 시장 성장을 저해하는 요인으로 작용하고 있습니다. 반면, 안과 질환의 수는 지속적으로 증가하고 있으며, 이는 향후 유리체망막 수술 기기의 채택을 촉진할 것으로 예상되며, Bright Focus Foundation이 2022년 10월에 발표한 팩트 시트에 따르면, 미국에서는 약 1,100만 명이 노화에 따른 황반변성 질환을 앓고 있다고 합니다. 재단은 2050년까지 이 숫자가 두 배인 2,200만 명에 육박할 것으로 예상하고 있으며, 이에 따라 치료용 기기의 사용이 불가피할 것으로 예상하고 있습니다.

부문 리뷰

유리체망막 수술 기기 시장은 제품, 수술 유형, 최종사용자, 지역으로 구분됩니다. 제품 기준으로 시장은 과불화탄소 액체, 내부 조명 기구, 망막 유리체 사전 충전 실리콘 오일 주사기, 유리체 수술 시스템 및 기타로 나뉩니다. 수술 유형에 따라 시장은 망막 전방 유리체 수술과 망막 후방 유리체 수술로 나뉩니다. 최종사용자에 따라 병원, 전문 클리닉, 외래 수술 센터로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

제품별로는 유리체 수술 시스템 부문이 2023년 시장을 장악했습니다.

수술 유형별로는 망막 전방 유리체 수술 부문이 2023년 시장에서 높은 점유율을 차지했습니다.

최종사용자별로는 병원 부문이 2023년 높은 시장 점유율을 차지했습니다.

지역별로는 북미가 2023년 가장 높은 수익을 올렸습니다.

이 보고서는 사용자 정의가 가능합니다.

• 규제 가이드라인
• 고객의 관심사에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 개요 확대 목록
• 과거 시장 데이터
• 주요 진입기업 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 유리체망막 수술 기기 시장 : 제품별

• 시장 개요
• 퍼플루오로카본 액체
• 내조식 기구
• 유리체망막용 프리필드 실리콘 오일 시린지
• 유리체 수술 시스템
• 기타

제5장 유리체망막 수술 기기 시장 : 수술 유형별

• 시장 개요
• 망막 전부 유리체 수술
• 망막 후부 유리체 수술

제6장 유리체망막 수술 기기 시장 : 최종사용자별

• 시장 개요
• 병원
• 전문 클리닉
• 외래 수술 센터

제7장 혈관 외과용 장비 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 유리체망막 수술 기기 시장
  • 캐나다의 유리체망막 수술 기기 시장
  • 멕시코의 유리체망막 수술 기기 시장
• 유럽
  • 주요 시장 동향과 기회
  • 독일의 유리체망막 수술 기기 시장
  • 프랑스의 유리체망막 수술 기기 시장
  • 영국의 유리체망막 수술 기기 시장
  • 이탈리아의 유리체망막 수술 기기 시장
  • 스페인의 유리체망막 수술 기기 시장
  • 기타 유럽의 유리체망막 수술 기기 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 일본의 유리체망막 수술 기기 시장
  • 중국의 유리체망막 수술 기기 시장
  • 호주의 유리체망막 수술 기기 시장
  • 인도의 유리체망막 수술 기기 시장
  • 한국의 유리체망막 수술 기기 시장
  • 기타 아시아태평양의 유리체망막 수술 기기 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 유리체망막 수술 기기 시장
  • 사우디아라비아의 유리체망막 수술 기기 시장
  • 남아프리카공화국의 유리체망막 수술 기기 시장
  • 기타 라틴아메리카, 중동 및 아프리카 유리체망막 수술 기기 시장

제8장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 10개 기업 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• Bausch And Lomb
• Novartis AG
• Inami And Co
• Paragon Care Group Pty Ltd
• Oculus Inc
• MedOne Surgical, Inc
• Carl Zeiss Meditec AG
• Peregrine Surgical
• Johnson And Johnson
• Blink Medical

ksm

영문 목차

영문목차

Vitreoretinal Surgery Devices

The vitreoretinal surgery devices market was valued at $2.3 billion in 2023 and is projected to reach $4.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Vitreoretinal surgery devices are the specialized equipment essential to perform ophthalmic surgeries focused on retina and vitreous humor of eyes. Diverse retinal conditions such as macular holes, retinal detachments, diabetic retinopathy, and epiretinal membranes are treated using these devices for the repair & restoration of the normal anatomy and function of the eyes. Innovations in devices allow surgeries to be performed with minimal invasion, hence lowering the recovery times and improving patient outcomes.

Increase in the prevalence of eye surgeries, particularly among the old generation, is a key driver of the vitreoretinal surgery devices market. In addition, rise in expenditure by the government toward healthcare facilities has led to advancements in the vitreoretinal surgery devices, which is boosting their adoption in the healthcare settings. Currently, the integration of robotics technology into surgery devices is an emerging trend in the market. The technology exceeds human skills in such complex surgeries, reducing the possibility of errors and enhancing the precision. The researchers aim to create smart surgery procedures by the assimilation of robotics and AI.

However, the high upfront costs of procuring the vitreoretinal surgery devices, along with their maintenance requirements deters various small-scale healthcare facilities from investing in them. This restrains the market growth in various developing and underserved regions. Contrarily, the constantly rising numbers of eye conditions are projected to boost the adoption of vitreoretinal surgery devices in the future. According to a factsheet released by Bright Focus Foundation on October 2022, approximately 11 million individuals in the U.S. suffer from some form of age-related macular degeneration. The foundation anticipates the number to double to nearly 22 million by 2050, hence compelling the use of the devices for treatment.

Segment Review

The vitreoretinal surgery devices market is segmented into product, surgery type, end user, and region. On the basis of product, the market is divided into perfluorocarbon liquids, endoillumination instrument, vitreoretinal prefilled silicone oil syringes, vitrectomy system, and other. Depending on surgery type, the market is bifurcated into anterior vitreoretinal surgery and posterior vitreoretinal surgery. As per end user, it is categorized into hospitals, specialty clinics, and ambulatory surgery centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the vitrectomy system segment dominated the market in 2023.

Depending on surgery type, the anterior vitreoretinal surgery segment acquired a high stake at the market in 2023.

As per end user, the hospitals segment accounted for a high market share in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global vitreoretinal surgery devices market include Bausch & Lomb, Novartis AG, Inami & Co, Paragon Care Group Pty Ltd, Oculus Inc, MedOne Surgical, Inc, Carl Zeiss Meditec AG, Peregrine Surgical, Johnson & Johnson, and Blink Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

• Perfluorocarbon Liquids
• Endoillumination Instrument
• Vitreoretinal Prefilled Silicone Oil Syringes
• Vitrectomy System
• Other

By Surgery Type

• Anterior Vitreoretinal Surgery
• Posterior Vitreoretinal Surgery

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Bausch & Lomb
• Novartis AG
• Inami & Co
• Paragon Care Group Pty Ltd
• Oculus Inc
• MedOne Surgical, Inc
• Carl Zeiss Meditec AG
• Peregrine Surgical
• Johnson & Johnson
• Blink Medical

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: VITREORETINAL SURGERY DEVICES MARKET, BY PRODUCT

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Product
• 4.2. Perfluorocarbon Liquids
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Endoillumination Instrument
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Vitreoretinal Prefilled Silicone Oil Syringes
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country
• 4.5. Vitrectomy System
  • 4.5.1. Key Market Trends, Growth Factors and Opportunities
  • 4.5.2. Market Size and Forecast, By Region
  • 4.5.3. Market Share Analysis, By Country
• 4.6. Other
  • 4.6.1. Key Market Trends, Growth Factors and Opportunities
  • 4.6.2. Market Size and Forecast, By Region
  • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: VITREORETINAL SURGERY DEVICES MARKET, BY SURGERY TYPE

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Surgery Type
• 5.2. Anterior Vitreoretinal Surgery
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Posterior Vitreoretinal Surgery
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: VITREORETINAL SURGERY DEVICES MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospitals
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Specialty Clinics
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Ambulatory Surgery Centers
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: VITREORETINAL SURGERY DEVICES MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Product
  • 7.2.3. Market Size and Forecast, By Surgery Type
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Vitreoretinal Surgery Devices Market
    • 7.2.6.1. Market Size and Forecast, By Product
    • 7.2.6.2. Market Size and Forecast, By Surgery Type
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Vitreoretinal Surgery Devices Market
    • 7.2.7.1. Market Size and Forecast, By Product
    • 7.2.7.2. Market Size and Forecast, By Surgery Type
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Vitreoretinal Surgery Devices Market
    • 7.2.8.1. Market Size and Forecast, By Product
    • 7.2.8.2. Market Size and Forecast, By Surgery Type
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Product
  • 7.3.3. Market Size and Forecast, By Surgery Type
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. Germany Vitreoretinal Surgery Devices Market
    • 7.3.6.1. Market Size and Forecast, By Product
    • 7.3.6.2. Market Size and Forecast, By Surgery Type
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. France Vitreoretinal Surgery Devices Market
    • 7.3.7.1. Market Size and Forecast, By Product
    • 7.3.7.2. Market Size and Forecast, By Surgery Type
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. UK Vitreoretinal Surgery Devices Market
    • 7.3.8.1. Market Size and Forecast, By Product
    • 7.3.8.2. Market Size and Forecast, By Surgery Type
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Italy Vitreoretinal Surgery Devices Market
    • 7.3.9.1. Market Size and Forecast, By Product
    • 7.3.9.2. Market Size and Forecast, By Surgery Type
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. Spain Vitreoretinal Surgery Devices Market
    • 7.3.10.1. Market Size and Forecast, By Product
    • 7.3.10.2. Market Size and Forecast, By Surgery Type
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Vitreoretinal Surgery Devices Market
    • 7.3.11.1. Market Size and Forecast, By Product
    • 7.3.11.2. Market Size and Forecast, By Surgery Type
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Product
  • 7.4.3. Market Size and Forecast, By Surgery Type
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. Japan Vitreoretinal Surgery Devices Market
    • 7.4.6.1. Market Size and Forecast, By Product
    • 7.4.6.2. Market Size and Forecast, By Surgery Type
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. China Vitreoretinal Surgery Devices Market
    • 7.4.7.1. Market Size and Forecast, By Product
    • 7.4.7.2. Market Size and Forecast, By Surgery Type
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. Australia Vitreoretinal Surgery Devices Market
    • 7.4.8.1. Market Size and Forecast, By Product
    • 7.4.8.2. Market Size and Forecast, By Surgery Type
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. India Vitreoretinal Surgery Devices Market
    • 7.4.9.1. Market Size and Forecast, By Product
    • 7.4.9.2. Market Size and Forecast, By Surgery Type
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. South Korea Vitreoretinal Surgery Devices Market
    • 7.4.10.1. Market Size and Forecast, By Product
    • 7.4.10.2. Market Size and Forecast, By Surgery Type
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Vitreoretinal Surgery Devices Market
    • 7.4.11.1. Market Size and Forecast, By Product
    • 7.4.11.2. Market Size and Forecast, By Surgery Type
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Product
  • 7.5.3. Market Size and Forecast, By Surgery Type
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Vitreoretinal Surgery Devices Market
    • 7.5.6.1. Market Size and Forecast, By Product
    • 7.5.6.2. Market Size and Forecast, By Surgery Type
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. Saudi Arabia Vitreoretinal Surgery Devices Market
    • 7.5.7.1. Market Size and Forecast, By Product
    • 7.5.7.2. Market Size and Forecast, By Surgery Type
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. South Africa Vitreoretinal Surgery Devices Market
    • 7.5.8.1. Market Size and Forecast, By Product
    • 7.5.8.2. Market Size and Forecast, By Surgery Type
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Vitreoretinal Surgery Devices Market
    • 7.5.9.1. Market Size and Forecast, By Product
    • 7.5.9.2. Market Size and Forecast, By Surgery Type
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Bausch And Lomb
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Novartis AG
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Inami And Co
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Paragon Care Group Pty Ltd
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Oculus Inc
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. MedOne Surgical, Inc
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Carl Zeiss Meditec AG
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. Peregrine Surgical
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Johnson And Johnson
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Blink Medical
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료